Obermeyer Wealth Partners Has $462,000 Stake in Danaher Co. (NYSE:DHR)

Obermeyer Wealth Partners raised its holdings in Danaher Co. (NYSE:DHR) by 25.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,012 shares of the conglomerate’s stock after buying an additional 410 shares during the period. Obermeyer Wealth Partners’ holdings in Danaher were worth $462,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in DHR. Minot DeBlois Advisors LLC bought a new stake in Danaher during the fourth quarter worth about $1,606,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Danaher by 7.4% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 63,534 shares of the conglomerate’s stock worth $14,584,000 after purchasing an additional 4,388 shares during the last quarter. Investor s Fiduciary Advisor Network LLC acquired a new position in shares of Danaher during the 4th quarter worth approximately $1,197,000. Janus Henderson Group PLC raised its stake in shares of Danaher by 1.3% during the 4th quarter. Janus Henderson Group PLC now owns 3,933,078 shares of the conglomerate’s stock worth $902,846,000 after purchasing an additional 50,283 shares in the last quarter. Finally, Humankind Investments LLC boosted its holdings in shares of Danaher by 21.5% in the 4th quarter. Humankind Investments LLC now owns 3,952 shares of the conglomerate’s stock valued at $907,000 after buying an additional 700 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Trading Down 2.1%

Shares of NYSE:DHR opened at $196.60 on Wednesday. The business’s 50 day simple moving average is $197.83 and its 200 day simple moving average is $218.54. Danaher Co. has a 1 year low of $171.00 and a 1 year high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The company has a market capitalization of $140.70 billion, a P/E ratio of 37.23, a P/E/G ratio of 2.66 and a beta of 0.80.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. The company had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. On average, research analysts anticipate that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.65%. Danaher’s dividend payout ratio (DPR) is presently 24.85%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on DHR shares. JPMorgan Chase & Co. lowered their target price on shares of Danaher from $280.00 to $260.00 and set an “overweight” rating on the stock in a report on Tuesday, April 22nd. The Goldman Sachs Group dropped their target price on shares of Danaher from $260.00 to $240.00 and set a “neutral” rating on the stock in a report on Wednesday, April 23rd. UBS Group reduced their price target on Danaher from $275.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 23rd. Stifel Nicolaus upgraded Danaher from a “hold” rating to a “buy” rating and set a $260.00 price objective on the stock in a research note on Friday, March 14th. Finally, Barclays raised their price objective on Danaher from $205.00 to $215.00 and gave the company an “overweight” rating in a research report on Tuesday, April 22nd. Four research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. According to data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $264.40.

Insider Buying and Selling

In related news, EVP Christopher Paul Riley sold 15,805 shares of the company’s stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the sale, the executive vice president now directly owns 15,179 shares in the company, valued at $3,005,442. This represents a 51.01% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 11.10% of the stock is currently owned by company insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.